SEOVF SERNOVA CORPORATION
- 0.280350
- 0.0000000.00%
SERNOVA CORPORATION News
Sernova Welcomes Dr. Bernd Muehlenweg as Evotec's Nominee for Its Board of Directors
Raymond James Initiates Coverage On Sernova With Market Perform Rating, Announces Price Target of $1.5
Raymond James analyst Rahul Sarugaser initiates coverage on Sernova (OTC:SEOVF) with a Market Perform rating and announces Price Target of $1.5.
Sernova Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/04/2024 277.41% Raymond James → $1.5 Initiates Coverage On → Market Perform
Sernova Reports Anticipated 2024 Milestones
Sernova Gets FDA Orphan Drug, Rare Pediatric Designations for Hemophilia A
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for Its Hemophilia A Program From FDA
LONDON, Ontario and WINDHAM COUNTY, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced the U.S.
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress
All six patients in the first cohort (Cohort A) were successfully implanted with the 8-channel Cell Pouch System with post-transplant follow-up periods ranging from 6 months to 3.5 years;5 of 6 patients in Cohort A
Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
Dr. Piotr Witkowski presenting new data from ongoing Phase 1/2 clinical trial of the Cell Pouch System in patients with type 1 diabetes (T1D) Dr. Alice Tomei presenting preclinical data on transplantation of
Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it has
Slone Partners Places Cynthia Pussinen as Chief Executive Officer and Member of the Board of Directors at Sernova Corporation
Industry veteran will lead the company's next stage of growth and development SOUTH RIDING, Va., Sept. 14, 2023 /PRNewswire-PRWeb/ -- Slone Partners, a nationwide executive search firm for life sciences, healthcare,
Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
- Introduction of New CEO Cynthia Pussinen and Recently Appointed Chief Business Officer, Dr. Modestus Obochi, on September 15, 2023 - - Business Update, Strategy & Outlook Call on October 5, 2023 - LONDON,
Sernova Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination With Cell Pouch Device
LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today provided a
Sernova Appoints CEO
Sernova Corporation Announces the Appointment of Cynthia Pussinen as CEO
Sernova Announces Positive Updated Interim Phase 1/2 Clinical Data for the Cell Pouch System at American Diabetes Association 83rd Scientific Sessions
In the first cohort of the ongoing Phase 1/2 clinical trial, the first 5 patients to complete protocol-defined islet transplants achieved insulin-independence for ongoing periods of 6 to 38 months.Following islet
Sernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System During Oral Presentation at American Diabetes Association 83rd Scientific Sessions
Company to host in-person only analyst and investor event at an offsite location following the presentation on Saturday, June 24 at the ADA Scientific SessionsLONDON, Ontario, June 22, 2023 (GLOBE N
Sernova to Participate in Upcoming Truist Securities Cell Therapy Symposium
LONDON, Ontario, June 16, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it will be partici
Sernova Announces Executive Alignment and Appoints New Board Chair
LONDON, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, today announced the outcomes fro
Sernova Shares Jump With AstraZeneca Collaboration
Sernova's shares rallied Wednesday after the biotechnology company entered a preclinical research collaboration with AstraZeneca to evaluate the use of its Cell Pouch System in combination with AstraZeneca's novel therapeutic cells.
Sernova Has Entered Into A Preclinical Research Collaboration With AstraZeneca To Evaluate The Use Of Sernova's Cell Pouch System In Combination With AstraZeneca's Novel Therapeutic Cells, Deal Terms Were Not Disclosed
Under the terms of the collaboration, AstraZeneca will lead and completely fund the development of the cell technologies and pre-clinical activities in conjunction with Sernova. The discovery work is
Analysis
Price Target
No Data
